Skip to main content

Table 6 Association between vaginal infections, TV, specific pHR/HR HPV genotypes and abnormal cytology; OR from Logistic regression; p-value from LRT

From: Multiple HPV infections in female sex workers in Western Kenya: implications for prophylactic vaccines within this sub population

Vaginal infections and STIs

OR Model 1 (95% CI)

p-value

OR Model 2 (95% CI)

p-value

BV

0.9 (0.6–1.5)

0.8

0.8 (0.5–1.4)

0.5

TV

24.8 (12.7–48.3)

<0.001

30.0 (14.1–62.9)

<0.001

Candida spp

1.0 (0.5–1.7)

1.0

0.9 (0.5–1.7)

0.7

Multiple HPV infection

5.3 (2.9–9.7)

<0.001

3.7 (1.9–7.3)

<0.001

HPV 16

1.9 (0.8–4.5)

0.1

1.2 (0.5–3.2)

0.5

HPV 18

0.8 (0.3–2.1)

0.7

1.04 (0.4–2.8)

0.9

HPV 31

0.5 (0.2–1.5)

0.2

0.6 (0.2–1.7)

0.3

HPV 33

3.9 (0.05–293.9)

0.5

2.8 (0.03–254.6)

0.6

HPV 35

1.3 (0.6–3.0)

0.5

1.1 (0.5–2.7)

0.9

HPV 39

3.3 (1.3–8.7)

0.03

2.5 (0.9–7.1)

0.09

HPV 51

3.7 (1.6–8.6)

0.002

3.7 (1.5–9.0)

0.004

HPV 52

6.1 (2.8–13.3)

<0.001

4.0 (1.6–8.2)

0.002

HPV 53

2.0 (0.8–4.9)

0.1

1.4; (0.5–3.8)

0.5

HPV 56

2.5 (1.0–6.6)

0.06

2.0 (0.7–5.7)

0.2

HPV 58

0.9 (0.2–3.6)

0.9

1.1 (0.3–5.2)

0.9

HPV 66

1.2 (0.5–3.0)

0.7

1.0 (0.4–3.0)

0.9

HPV 68

1.7 (0.2–17.0)

0.7

0.8 (0.1–7.4)

0.8

  1. Model 1: OR adjusting for age, pHR/HR HPV genotypes, vaginal infections/TV
  2. Model 2: OR adjusting for age and pHR/HR genotypes, vaginal infections/TV and HIV